Drug Innovation Insights
Vinay discusses the dual nature of drug development, highlighting the life-saving potential of new medications while questioning the balance between efficiency and waste in the system. He emphasizes the excitement surrounding innovation and its role in attracting top talent, yet raises concerns about the prevalence of mediocre drugs. The conversation explores how a more market-driven approach could reshape decisions around healthcare spending and drug accessibility.In this clip
From this podcast
EconTalk
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Related Questions
What do you think about the pharmaceutical industry?
What are other criticisms of big pharma in relation to the episodes Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty and Honoring the Elderly?
Why are pharmaceuticals so expensive, as discussed in the episode 1005: David Fajgenbaum | Leveraging AI to Cure Rare Diseases and the clip Drug Pricing Dilemma?